Frontiers in Clinical Diabetes and Healthcare

Economic evaluation of liraglutide versus sitagliptin in the treatment of type 2 diabetes mellitus inadequately controlled with metformin

By Fengkun Yang, Xiaohui Zheng, Wenqi Li, Zhenying Zhao

Computational studyInterventions

The paper

Fengkun Yang, Xiaohui Zheng, Wenqi Li, Zhenying Zhao

Nankai University

Frontiers in Clinical Diabetes and Healthcare, 7 Aug 2026

doi.org/10.3389/fcdhc.2026.1906364 PubMed 42630210

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety